Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Shalata

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Medical Sciences (Basel, Switzerland)|May 27, 2026
Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLCAbed Agbarya, Kamel Mhameed, Arina Soklakova, et al.
Biomedicines|September 28, 2023
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung CancerWalid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
International Journal of Molecular Sciences|August 26, 2023
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping MutationsUrska Janzic, Walid Shalata, Katarzyna Szymczak, et al.
The Israel Medical Association Journal : IMAJ|October 30, 2022
Novel Bronchoscopic Drainage Technique in Multiple Drug Resistant Acinetobacter Lung Abscess: A Case ReportWalid Shalata, Motaz Abo Abod, Sergei Tsaregorodtsev, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening MyelosuppressionWalid Shalata, Ashraf Abu Jama, Yulia Dudnik, et al.
Journal of Personalized Medicine|November 25, 2023
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World ExperienceKeren Rouvinov, Gal Mazor, Ella Kozlener, et al.
International Journal of Molecular Sciences|June 19, 2024
Melanoma Management: Exploring Staging, Prognosis, and Treatment InnovationsWalid Shalata, Zoe Gabrielle Attal, Adam Solomon, et al.
Biomedicines|July 27, 2024
Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment OptionsZoe Gabrielle Attal, Walid Shalata, Arina Soklakova, et al.
Life (Basel, Switzerland)|October 29, 2025
Impact of Gastrojejunostomy Configuration on Delayed Gastric Emptying Following Pancreaticoduodenectomy: A Single-Surgeon Retrospective StudyForat Swaid, Muhammad Masalha, Rajaa Elias, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective StudyAbed Agbarya, Walid Shalata, Edmond Sabo, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Medical Sciences (Basel, Switzerland)|May 27, 2026
Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLCAbed Agbarya, Kamel Mhameed, Arina Soklakova, et al.
Biomedicines|September 28, 2023
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung CancerWalid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
International Journal of Molecular Sciences|August 26, 2023
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping MutationsUrska Janzic, Walid Shalata, Katarzyna Szymczak, et al.
The Israel Medical Association Journal : IMAJ|October 30, 2022
Novel Bronchoscopic Drainage Technique in Multiple Drug Resistant Acinetobacter Lung Abscess: A Case ReportWalid Shalata, Motaz Abo Abod, Sergei Tsaregorodtsev, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening MyelosuppressionWalid Shalata, Ashraf Abu Jama, Yulia Dudnik, et al.
Journal of Personalized Medicine|November 25, 2023
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World ExperienceKeren Rouvinov, Gal Mazor, Ella Kozlener, et al.
International Journal of Molecular Sciences|June 19, 2024
Melanoma Management: Exploring Staging, Prognosis, and Treatment InnovationsWalid Shalata, Zoe Gabrielle Attal, Adam Solomon, et al.
Biomedicines|July 27, 2024
Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment OptionsZoe Gabrielle Attal, Walid Shalata, Arina Soklakova, et al.
Life (Basel, Switzerland)|October 29, 2025
Impact of Gastrojejunostomy Configuration on Delayed Gastric Emptying Following Pancreaticoduodenectomy: A Single-Surgeon Retrospective StudyForat Swaid, Muhammad Masalha, Rajaa Elias, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective StudyAbed Agbarya, Walid Shalata, Edmond Sabo, et al.
Pageof 8